Singapore, Singapore--(Newsfile Corp. - November 17, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced that its co-founder, co-CEO, COO, and Chairwoman of the Board, Dr. Teoh Pui Pui, has acquired additional shares of the company's Class A Ordinary Shares through an independent open market transaction. According to a Schedule 13D filed today with the U.S. Securities and Exchange Commission, Dr. Teoh purchased 0.4% of MNDR's outstanding Class A Ordinary Shares on November 5, 2025, for a total consideration of approximately US$8,751.32.

image for news Mobile-health Network Solutions Co-CEO Teoh Pui Pui Increases Equity Stake Through Open Market Purchase

Datavault AI Inc. (DVLT) Q3 2025 Earnings Call Transcript — Neutral

DVLT   Seeking Alpha — November 17, 2025

Datavault AI Inc. ( DVLT ) Q3 2025 Earnings Call November 17, 2025 8:30 AM EST Company Participants Nathaniel Bradley - President, CEO & Director Brett Moyer - Chairman & CFO Conference Call Participants Ken Londoner Jack Vander Aarde - Maxim Group LLC, Research Division Presentation Operator Good morning, and welcome to Datavault AI's Third Quarter Conference Call. With us today are Nathaniel Bradley, CEO; and Brett Moyer, CFO.

image for news Datavault AI Inc. (DVLT) Q3 2025 Earnings Call Transcript

The Energy Chart Nobody Is Paying Attention To, But It Could Change Everything — Positive

AMLP  BOTZ  EPD  ET  KMI  LNG  OKE  TRP  WMB  XLE   Seeking Alpha — November 17, 2025

I share the one chart that is not getting nearly enough attention, given its immense implications for the world economy. This chart reveals a massive power shift that markets haven't priced in, and it could reshape the entire future of AI, manufacturing, and geopolitics. I detail how I am positioning my portfolio to take advantage of it.

image for news The Energy Chart Nobody Is Paying Attention To, But It Could Change Everything

New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline. SO WHAT: If you purchased MoonLake common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news ROSEN, SKILLED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX

Hudson Pacific Properties Announces Reverse Stock Split — Neutral

HPP   Business Wire — November 17, 2025

LOS ANGELES--(BUSINESS WIRE)--Hudson Pacific Properties, Inc. ("Hudson Pacific" or the "Company") (NYSE: HPP) today announced that it will effect a 1-for-7 reverse stock split (the "Reverse Stock Split") of its common stock, par value $0.01 per share ("Common Stock") that will become effective at 5:00 p.m. Eastern Time on December 1, 2025 (the "Effective Time"). The Company expects that its Common Stock will open for trading on the New York Stock Exchange ("NYSE") on a reverse split-adjusted ba.

image for news Hudson Pacific Properties Announces Reverse Stock Split

Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point — Positive

TECX   Seeking Alpha — November 17, 2025

Tectonic Therapeutic, Inc. achieved positive results from Part B of the phase 1b study targeting pulmonary hypertension in heart failure with reduced ejection fraction (PH-HFrEF) patients. TECX is targeting CpcPH patients with PVR >3 in the ongoing phase 2 APEX study of PH-HFpEF, with topline data expected in 2026 and expansion into PH-ILD planned then also. TECX holds $268.4 million in cash, sufficient to fund operations into Q4 2028 and support multiple clinical milestones, including several catalysts.

image for news Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point

First Guaranty Bancshares (FGBI) Reports Q3 Loss, Misses Revenue Estimates — Negative

FGBI   Zacks Investment Research — November 17, 2025

First Guaranty Bancshares (FGBI) came out with a quarterly loss of $2.16 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to earnings of $0.11 per share a year ago.

image for news First Guaranty Bancshares (FGBI) Reports Q3 Loss, Misses Revenue Estimates

New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quanex Building Products Corporation (NYSE: NX) between December 12, 2024 and September 5, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Quanex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news NX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Quanex Building Products Corporation Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action - NX

MCLEAN, VA / ACCESS Newswire / November 17, 2025 / Gladstone Capital Corporation (Nasdaq:GLAD) (the "Company") today announced earnings for its fourth quarter and fiscal year ended September 30, 2025. Please read the Company's Annual Report on Form 10-K filed today with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website at www.sec.gov and the Investors section of the Company's website at www.GladstoneCapital.com.

image for news Gladstone Capital Corporation Reports Financial Results for its Fourth Quarter and Fiscal Year Ended September 30, 2025

TULSA, Okla.--(BUSINESS WIRE)--Helmerich & Payne, Inc. (NYSE: HP) Operating and Financial Highlights for the Quarter Ended September 30, 2025 The Company realized a consolidated net loss of $(57) million, or $(0.58) per share, which includes the impact of non-recurring charges of $56 million. Adjusted for this and other non-recurring one-time items, adjusted net loss(1) was $(1) million, or $(0.01) per share. The Company has received notifications for seven rigs to resume operations in Saud.

image for news Helmerich & Payne, Inc. Announces Fiscal Fourth Quarter and Fiscal 2025 Results and Provides Initial Fiscal Year 2026 Operating and Financial Guidance

Spread Compression Makes These Bond ETFs Appealing — Positive

VTC  VWOB   ETF Trends — November 17, 2025

Tightening credit spreads can create opportunities for fixed income investors to maximize in the current bond environment. In its latest iteration of Active Fixed Income Perspectives, Vanguard noted this spread compression across the full credit market spectrum during Q3.

image for news Spread Compression Makes These Bond ETFs Appealing

Fidelity sues Broadcom over access to key software to avoid outages — Negative

AVGO   Reuters — November 17, 2025

A subsidiary of Fidelity Investments has filed a lawsuit accusing technology company Broadcom of threatening to cut off its access to key software that has become central to the financial firm's systems, creating the risk of "massive outages" and trading disruptions unless a judge intervenes to stop it.

image for news Fidelity sues Broadcom over access to key software to avoid outages

Gary Haase to Join Everest as EVP, CEO of Legacy Operations — Neutral

EG   Business Wire — November 17, 2025

HAMILTON, Bermuda--(BUSINESS WIRE)--Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing world-class reinsurance and specialty insurance solutions, today announced the appointment of Gary Haase as Executive Vice President and CEO of Legacy Operations, effective December 1, 2025. He will report to Jim Williamson, Everest's President and CEO, and will join the Company's Executive Leadership Team. The appointment follows Everest's recent $2B renewal rights sale of its commercial.

image for news Gary Haase to Join Everest as EVP, CEO of Legacy Operations

LAS VEGAS--(BUSINESS WIRE)--Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) today announced that it has released an investor presentation in connection with its 2025 Annual Meeting of Shareholders (the “Annual Meeting”) to be held on December 12, 2025. All Cannae shareholders of record as of the close of business on October 30, 2025, will be entitled to vote at the Annual Meeting. The presentation can be found at www.cannaeholdings.com. Over the past 21 months, Cannae has shifted.

image for news Cannae Holdings, Inc. Releases Investor Presentation Highlighting Superior Board Nominees and Path to Unlock Further Long-Term Value

NEWCASTLE & HOUSTON--(BUSINESS WIRE)--TechnipFMC (NYSE: FTI) has been awarded a substantial(1) integrated Engineering, Procurement, Construction, and Installation (iEPCITM) contract by Eni SpA (ENI.MI) for the deepwater Maha project offshore Indonesia. The project represents Eni's first deployment of TechnipFMC's Subsea 2.0® configure-to-order (CTO) technology in Indonesia. The award leverages experience gained through a series of successful projects with Eni in the region, including Jangkrik a.

image for news TechnipFMC Awarded Substantial iEPCI™ Contract for Eni's Maha Project in Indonesia

Fennec Pharmaceuticals Announces Closing of Offering of Common Shares — Neutral

FENC   GlobeNewsWire — November 17, 2025

RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the closing of its underwritten registered public offering of 5,366,667 common shares (which amount includes exercise in full of the underwriters' option to purchase additional common shares) at a public offering price of $7.50 per share. Fennec's total gross proceeds from the offering (before deducting the underwriting discounts and offering expenses) are approximately $40,250,000.

image for news Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

nVent Unveils New Liquid Cooling and Power Portfolio at SC25 — Neutral

NVT   Business Wire — November 17, 2025

ST. LOUIS--(BUSINESS WIRE)---- $NVT #SC25--nVent Electric plc (NYSE:NVT) (“nVent”), a global leader in electrical connection and protection solutions, today announced its new, modular data center liquid cooling solutions aligned to chip manufacturers' current and future cooling requirements. The new solutions include enhanced coolant distribution unit (CDU) offerings with new row and rack-based CDUs alongside advanced technology cooling system manifolds. They also include updated racks based on leading refere.

image for news nVent Unveils New Liquid Cooling and Power Portfolio at SC25

Microchip Technology to Present at the Wells Fargo 9th Annual TMT Summit — Neutral

MCHP   GlobeNewsWire — November 17, 2025

CHANDLER, Ariz., Nov. 17, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Wells Fargo 9th Annual TMT Summit on Tuesday, November 18, 2025 at 12:45 p.m. (Pacific Time). Presenting for the Company will be Mr. Eric Bjornhoolt, Senior Vice President and Chief Financial Officers, and Mr. Sajid Daudi, Head of Investor Relations. A live webcast of the presentation will be made available by Wells Fargo, and can be accessed on the Microchip website at www.microchip.com.

image for news Microchip Technology to Present at the Wells Fargo 9th Annual TMT Summit

Crescent Biopharma Announces Grants of Inducement Awards — Neutral

CBIO   GlobeNewsWire — November 17, 2025

WALTHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 451,448 shares of the Company's ordinary shares to eight non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on November 14, 2025 and were material to each employee's acceptance …

image for news Crescent Biopharma Announces Grants of Inducement Awards

SmartRent Names Sangeeth Ponathil Chief Information Officer — Neutral

SMRT   Business Wire — November 17, 2025

PHOENIX--(BUSINESS WIRE)---- $SMRT #alloy--SmartRent today announced the appointment of Sangeeth Ponathil as Chief Information Officer.

image for news SmartRent Names Sangeeth Ponathil Chief Information Officer